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Purpose/Objective: European authorities and scientific 
societies have advised that patient safety be analyzed and 
adequately managed. Thus, we present a set of tools and 
measures we studied in order to reinforce patient safety in 
Intraoperative electron radiotherapy (IOERT). 
Materials and Methods: We performed a Failure mode and 
effect analysis (FMEA) which was used to centralize all the 
information regarding patient safety in IOERT. Safety 
elements included tools such as in vivo dosimetry in 40 valid 
cases, statistical process control (SPC) of electron beam 
monitoring, checklists design and implementation, and other 
insights unveiled by the FMEA like the necessity for checking 
several actions taken by involved professionals. In vivo 
dosimetry was performed with reinforced MOSFETs model TN-
502RDM-H (Best Medical Canada Ltd., Ottawa, Canada). 
Electron beam monitoring was carried out with the daily 
checking device, Daily QA Check 1090 (Sun Nuclear 
Corporation, Melbourne, USA), which controlled our Elekta 
Precise linac (Elekta AB, Stockholm, Sweden) used for the 
IOERT treatments. Our checklists were related to procedures 
and materials managed by anesthesiologists, surgeons, 
radiation oncologists, nurses, radiation therapists, and 
medical physicists. They were divided in blocks and timeouts. 
Results: The FMEA was a very fruitful tool to identify all 
potential risks and allocate measures in order to reduce such 
risks and reinforce patient safety. In vivo dosimetry 
confirmed our treatments as correct, with a delivered 
measured absorbed dose of 93.8% on average (with a 
standard deviation of 6.7%), compared to an expected dose 
to the tumor bed between the prescribed dose (90%) and the 
maximum dose (100%). SPC led to uneasy-to-implement 
conclusions due to its high sensitivity compared to linac 
output fluctuations. As an example, absorbed dose delivered 
with 9 MeV beams would require to be adjusted one quarter 
of the times they are checked in order to achieve a feasible 
control band of 1.15% calculated with their SPC. Checklists 
were feasible and easy to write, but require a strong 
commitment of the multidisciplinary team to be operative, 
namely the strict fulfillment of blocks at timeouts. Other 
necessary elements are double checking of human decisions, 
also easy to implement, and requests for automation 
whenever possible, which need engagement of companies to 
be solved. 
 
 
 
Conclusions: FMEA can be the main tool to identify 
opportunities for patient safety reinforcing, and can produce 
a central board to which fit risk reduction elements and 
actions. As examples, these measures and tools can be an in 
vivo dosimetry program, checklists, checking of human 
decision-making, and automation of several processes. 
Nevertheless, SPC needs further research before being 
integrated. This approach can be extended to other 
radiotherapy procedures. 
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Purpose/Objective: The increasingly attractive stereotactic 
body radiation therapy (SBRT) for stage I lung cancer is 
always accompanied by a large amount of monitor units (MU), 
particularly with a high dose fraction scheme. The study aims 
to find the optimal planning parameters in the treatment 
planning system optimizer to get the lowest monitor unit 
(MU) in lung SBRT. 
Materials and Methods: Fourteen patients suffered from 
peripheral or central stage I Non-Small Cell Lung Cancer 
(NSCLC) were enrolled. The upper objective of planning 
